Immunomodulatory and anti-tumor activities of native and heat denatured Abrus agglutinin

Immunobiology

Volumn 212, Issue 7, 2007, Pages 589-599

  Ghosh, Dipanjan ^a   Maiti, Tapas K ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY   (India)

Author keywords

Abrus agglutinin; Anti tumor; Dalton's lymphoma; Heat denatured; Immunoadjuvant; Immunomodulator; Lectin

Indexed keywords

AGGLUTININ; PLANT LECTIN;

ABRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL COUNT; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELLULAR IMMUNITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DENATURATION; DISEASE MODEL; DRUG MECHANISM; GROWTH INHIBITION; HEATING; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; LYMPHOMA; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; SURVIVAL TIME; TH1 CELL; TUMOR CELL;

EID: 34547204981     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2007.03.005     Document Type: Article

References (36)

1. Beuth J. Clinical relevance of immunoactive mistletoe lectin-I. Anticancer Drugs 8 (1997) S53-S55
2. Bingle L., Brown N.J., and Lewis C.E. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J. Pathol. 196 (2002) 254-265
3. Bremers A.J., and Parmiani G. Immunology and immunotherapy of human cancer: present concepts and clinical developments. Crit. Rev. Oncol. Hematol. 34 (2000) 1-25
4. Das S. Plant lectins in the prevention and control of tumor growth-future direction in cancer therapy?. Exp. Opin. Invest. Drugs. 4 (1995) 1293-1297
5. Dredge K., Marriott J.B., Todryk S.M., and Dalgleish A.G. Adjuvants and promotion of Th1-type cytokines in tumour immunotherapy. Cancer Immunol. Immunother. 51 (2002) 521-531
6. Gabius H.J. Probing the cons and pros of lectin induced immunomodulation, case studies for mistletoe lectin and galectin-1. Biochemie 83 (2001) 659-666
7. Ganguly C., and Das S. Anti-tumor activity of two plant lectins. Ind. J. Cancer Chemother. 13 (1991) 41-44
8. Ganguly C., and Das S. Plant lectins as inhibitors of tumor growth and modulators of host immune response. Chemotherapy 40 (1994) 272-278
9. Hadden J.W. Immunodeficiency and cancer: prospects for correction. Int. Immunopharmacol. 3 (2003) 1061-1071
10. Hajto T., Hostanska K., and Gabius H.J. Modulatory potency of the beta-galactoside-specific lectin from mistletoe extract (Iscador) on the host defense system in vivo in rabbits and patients. Cancer Res. 49 (1989) 4803-4808
11. Hajto T., Hostanska K., Berki T., Palinkas L., Boldizsar F., and Nemeth P. Oncopharmacological perspectives of a plant lectin (Viscum album Agglutinin-I): overview of recent results from in vitro experiments and in vivo animal models, and their possible relevance for clinical applications. eCAM 2 (2005) 59-67
12. Hegde R., Maiti T.K., and Podder S.K. Purification and characterization of three toxins and two agglutinins from Abrus precatorius seeds by using lactamyl-sepharose affinity chromatography. Anal. Biochem. 194 (1991) 101-109
13. Karasaki Y., Tsukamoto S., Mizusaki K., Sugiura T., and Gotoh S. A garlic lectin exerted an antitumour activity and induced apoptosis in human tumor cells. Food Res. Int. 34 (2001) 7-13
14. Knolle P.A., Gerken G., Loser E., Dienes H.P., Gantner F., Tiegs G., Meyer zum Buschenfelde K.H., and Lohse A.W. Role of sinusoidal endothelial cells of the liver in concanavalinA-induced hepatic injury in mice. Hepatology 24 (1996) 824-829
15. Leist M., and Wendel A. A novel mechanism of murine hepatocyte death inducible by concanavalin. J. Hepatol. 25 (1996) 948-959
16. Liu C.L., Tsai C.C., Lin S.C., Wang L.I., Hsu C.I., Hwang M.J., and Lin J.Y. Primary structure and function analysis of the Abrus precatorius Agglutinin A chain by side-directed mutagenesis. J. Biol. Chem. 275 (2000) 1897-1901
17. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall RJ. Protein measurement using the folin phenol reagent. J. Biol. Chem. 193 (1951) v265
18. Moon E.Y., Rhee D.K., and Pyo S. In vitro suppressive effects of aflatoxin B1 on murine peritoneal macrophage functions. Toxicology 133 (1999) 171-179
19. Mosmann T. Rapid colorimetric assay for cellular growth and survival, application to proliferation and cytotoxicity assays J. Immunol. Methods 65 (1983) 55-63
20. Ohm J.E., and Carbone D.P. VEGF as a mediator of tumor-associated immunodeficiency. Immunol. Res. 23 (2001) 263-272
21. Olsnes S., Saltvedt E., and Pihl A. Isolation and comparison of galactose-binding lectins from Abrus precatorius and Ricinus communis. J. Biol. Chem. 249 (1974) 803-810
22. Ooi V.E., and Liu F. Immunomodulation and anti-cancer activity of polysaccharide-protein complexes. Curr. Med. Chem. 7 (2000) 715-729
23. Pollard J.W. Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer 4 (2004) 71-78
24. Schon M.P., and Schon M. Immune modulation and apoptosis induction: two sides of the antitumoral activity of imiquimod. Apoptosis 9 (2004) 291-298
25. Suryakala S., Maiti T.K., Sujatha N., and Sashidhar R.B. Identification of a novel protein adjuvant isolated from Abrus precatorius. Food Agric. Immunol. 12 (2000) 87-96
26. Tripathi S., and Maiti T.K. Stimulation of murine macrophages by native and heat denatured lectin from Abrus precatorius. Int. Immunopharmacol. 3 (2003) 375-381
27. Tripathi S., and Maiti T.K. Efficiency of heat denatured lectins from Abrus precatorius as immunoadjuvants. Food Agric. Immunol. 15 (2003) 279-287
28. Tripathi S., and Maiti T.K. Immunomodulatory role of native and heat denatured agglutinin from Abrus precatorius. Int. J. Biochem. Cell. Biol. 37 (2005) 451-462
29. Tung T.C., Chang H.C., Hsu Y.M., Hsu C.T., and Lin J.Y. Tumor immunity induction in inbred BALB/c mice by Abrus agglutinin treated Meth-A fibrosarcoma cells. Taiwan Yi Xue Hui Za Zhi 78 (1979) 605-607
30. Tung T.C., Yang T.T., Chang H.C., Hsu Y.M., and Lin J.Y. The growth inhibition of S-180 sarcoma cells by Abrus agglutinin treatment in vivo. Taiwan Yi Xue Hui Za Zhi 80 (1981) 1-6
31. Valiante N.M., O'Hagan D.T., and Ulmer J.B. Innate immunity and biodefence vaccines. Cell Microbiol. 5 (2003) 755-760
32. Wang H.X., Ng T.B., Ooi V.E., Liu W.K., and Chang S.T. Actions of lectins from the mushroom Tricholoma mongolicum on macrophages, splenocytes and life-span in sarcoma-bearing mice. Anticancer Res. 17 (1997) 419-424
33. Werling D., and Jungi T.W. Toll-like receptors linking innate and adaptive immune response. Vet. Immunol. Immunopathol. 91 (2003) 1-12
34. Wimer B.M. Characteristics of PHA-L4, the mitogenic isolectin of phytohemagglutinin as an ideal biological response modifier. Mol. Biother. 2 (1990) 4-17
35. Wimer B.M. Curative potential of foremost mitogen applications. Cancer Biother. Radiopharm. 18 (2003) 903-916
36. Zou W. Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat. Rev. Cancer 5 (2005) 263-274